0001415889-23-004973.txt : 20230315
0001415889-23-004973.hdr.sgml : 20230315
20230315200010
ACCESSION NUMBER: 0001415889-23-004973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230314
FILED AS OF DATE: 20230315
DATE AS OF CHANGE: 20230315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iwicki Mark T
CENTRAL INDEX KEY: 0001415537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 23736749
MAIL ADDRESS:
STREET 1: 84 WATERFORD DRIVE
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1167 MASSACHUSETTS AVENUE
CITY: ARLINGTON
STATE: MA
ZIP: 02476
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 1167 MASSACHUSETTS AVENUE
CITY: ARLINGTON
STATE: MA
ZIP: 02476
4
1
form4-03152023_080301.xml
X0306
4
2023-03-14
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001415537
Iwicki Mark T
C/O KALA PHARMACEUTICALS, INC.
1167 MASSACHUSETTS AVENUE
ARLINGTON
MA
02476
true
true
false
false
CHIEF EXECUTIVE OFFICER
Stock Option (Right to Buy)
68.50
2023-03-14
4
A
0
1512
0
A
2032-01-03
Common Stock
1512
1512
D
On January 3, 2022, the Reporting Person was granted an option to purchase up to 5,670 shares of common stock of the Issuer. Specified portions of the options vest based on the level of achievement of specified performance metrics relating to financial, operational and scientific matters.
On March 14, 2023, the Compensation Committee of the Issuer's Board of Directors determined that certain of the performance conditions were achieved at specific levels of achievement, resulting in vesting of the option as to 1,512 shares of common stock. The Compensation Committee has made no determination with respect to certain performance metrics, which could result in the further vesting of up to 1,134 shares of common stock underlying the option.
/s/ Eric Trachtenberg, Attorney-in-Fact
2023-03-15